Elastin-derived peptides upregulate matrix metalloproteinase-2-ediated melanoma cell invasion through elastin-binding protein

被引:71
作者
Ntayi, C
Labrousse, AL
Debret, R
Birembaut, P
Bellon, G
Antonicelli, F
Hornebeck, W
Bernard, P
机构
[1] Univ Reims, Fac Med, Dept Dermatol, F-51100 Reims, France
[2] Univ Reims, Fac Med, Dept Biochem, CNRS,FRE 2534, F-51100 Reims, France
[3] Univ Reims, CHU Reims, Lab Pol Bouin, INSERM 514,IFR Biomol 53, F-51100 Reims, France
关键词
MMP; invasion;
D O I
10.1046/j.0022-202X.2004.22228.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Type I collagen mediates melanoma cells invasion through upregulation of matrix metalloproteinases-1 and -2 (MMP-1 and -2) expression and activation. We investigated here the contribution of elastin-derived peptides (ED), degradation products of elastin, the main component of elastic fibers in melanoma cells invasion and MMP-1 and -2 expression. Our results evidenced fragmentation of elastin at the invasive front of melanoma, particularly in the most invasive tumors where those fibers nearly totally vanished. By electron microscopy, elastolysis was found to occur mainly at the periphery of melanoma cells, where close contact between elastic fibers and cells could be noticed. Therefore, we showed in vitro that plating melanoma cells high tumorigenic potential on ED-coated dishes, selectively enhanced MMP-2, as membrane-type MMP-1 (MT1-MMP) production and activation. Nevertheless, pro-MMP-2 activation was not observed owing to the parallel increase in tissue inhibitor of metalloproteinase (TIMP)-2 expression. The effects of ED on melanoma cells were found to be mediated by splicing form of beta-galactosidase (S-Gal) occupancy, as being suppressed by lactose. Supplementing collagen lattices with ED led to consistent activation of MMP-2 that can be attributed to TIMP-2 downregulation. Upregulation of MMP-2 activation by ED led to enhanced melanoma cells invasion through S-Gal occupancy. Immunohistochemistry studies, confirmed that S-Gal expression was more prominent at the melanoma invasion site associated with a strong expression of MMP-2 and MT1-MMP. We hypothesize that ED following interactions with S-Gal elastin receptor can favor melanoma cells invasion through a three-dimensional type I collagen matrix by upregulating MMP-2 activation.
引用
收藏
页码:256 / 265
页数:10
相关论文
共 51 条
[1]  
[Anonymous], 1985, FRONT MATRIX BIOL
[2]  
BALCH CM, 2001, J SURG ONCOL, V78, P10
[3]   A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen [J].
Benbow, U ;
Schoenermark, MP ;
Mitchell, TI ;
Rutter, JL ;
Shimokawa, K ;
Nagase, H ;
Brinckerhoff, CE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (36) :25371-25378
[4]  
BERTHIERVERGNES O, 1985, J NATL CANCER I, V75, P605
[5]  
Berton A., 2000, Molecular Cell Biology Research Communications, V3, P173, DOI 10.1006/mcbr.2000.0210
[6]  
Bodey B, 2001, IN VIVO, V15, P57
[7]   Regulation of matrix metalloproteinase-2 (gelatinase A, MMP-2), membrane-type matrix matelloproteinase-1 (MT1-MMP) and tissue inhibitor of metalloproteinases-2 (TIMP-2) expression by elastin-derived peptides in human HT-1080 fibrosarcoma cell line [J].
Brassart, B ;
Randoux, A ;
Hornebeck, W ;
Emonard, H .
CLINICAL & EXPERIMENTAL METASTASIS, 1998, 16 (06) :489-500
[8]   Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts [J].
Brassart, B ;
Fuchs, P ;
Huet, E ;
Alix, AJP ;
Wallach, J ;
Tamburro, AM ;
Delacoux, F ;
Haye, B ;
Emonard, H ;
Hornebeck, W ;
Debelle, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) :5222-5227
[9]   Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth [J].
Buisson-Legendre, N ;
Bernard, P ;
Bobichon, H ;
Emonard, H ;
Schneider, C ;
Maquart, FX ;
Haye, B ;
Hornebeck, W .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 260 (03) :634-640
[10]   Expression and activation of pro-gelatinase A by human melanoma cell lines with different tumorigenic potential [J].
Capon, F ;
Emonard, H ;
Hornebeck, W ;
Maquart, FX ;
Bernard, P .
CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (06) :463-469